CUP CONTRACT LABS
LIVE

Serial Number

79403935

Owner

CUP Laboratorien Dr. Freitag GmbH

Attorney

Eleanor M. Yost

Filing Date

May 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CUP CONTRACT LABS Trademark

Serial Number: 79403935 • Registration: 7963077

CUP CONTRACT LABS is a trademark filed by CUP Laboratorien Dr. Freitag GmbH on May 7, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CUP Laboratorien Dr. Freitag GmbH (2 trademarks)

Carl-Eschebach-Str. 7

Entity Type: 98

Trademark Details

Filing Date

May 7, 2024

Registration Date

September 30, 2025

Published for Opposition

August 12, 2025

Goods & Services

Pharmaceutical research and development services; medical and pharmacological research services in the nature of laboratory research in the field of pharmaceuticals; scientific laboratory services, namely, laboratory analytical and quality assurance testing of pharmaceutical products; pharmaceutical product evaluation; analytical scientific laboratory services for pharmaceuticals; technological analysis services, namely, assays and biological tests of pharmaceutical preparations, sterility testing of pharmaceutical preparations, stability testing of pharmaceutical preparations, operational hygiene monitoring testing of pharmaceutical preparations, testing of physical and physiochemical properties of pharmaceutical preparations, limit testing of pharmaceutical preparations, dissolution and particle analysis of pharmaceutical preparations, pH testing of pharmaceutical preparations, density testing of pharmaceutical preparations, liquid and gas chromatography testing of pharmaceutical preparations, radioactivity testing of pharmaceutical preparations, mass spectrometry testing of pharmaceutical preparations; providing information about industrial analysis and research services in the field of pharmaceuticals; chemistry, biochemistry, microbiology and physics services namely, laboratory testing in the field of pharmaceuticals; providing technical and natural science expertise and research namely, technical consulting services in the field of developing pharmaceutical testing protocols and studies; development of analytical methods, namely, creating research and clinical tests for others relating to pharmaceutical products; consultancy relating to application technology and natural sciences in the nature of consulting services in the field of pharmaceutical research and development; microbiological testing of goods in the nature of pharmaceuticals; examinations of medicines and pharmaceutical raw materials, in particular radiopharmaceuticals, namely, sterility testing of radioactive pharmaceutical products, scientific analysis of precursors for radiopharmaceuticals, impurity testing of radiopharmaceuticals, testing for residual solvents for radiopharmaceuticals, and laboratory analysis of elemental impurities for radiopharmaceuticals; laboratory research services relating to pharmaceuticals; quality checking and testing of pharmaceutical products and preparations, namely, sterility testing, operational hygiene monitoring, dissolution and particle analysis, leachables/extractables studies, elemental analysis, gas chromatography, stability testing, and high-performance liquid chromatography (HPLC), all the foregoing for pharmaceutical products and preparations; materials testing and analyzing; testing of chemicals; working on and evaluation of chemical analyses; conducting sampling and analysis services to check for contamination of pharmaceutical preparations; microbiological testing, namely, microbiological examination of pharmaceutical products, microbial enumeration testing of pharmaceutical products, testing for test for bacterial endotoxins; clinical expertise, namely, technical consulting in the field of pharmaceutical studies; chemical analysis services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biological safety testing of pharmaceuticals and cosmetics; scientific laboratory testing in the fields of toxicology, clinical microbiology and intestinal microecology; Scientific research in the nature of conducting clinical trials for others; Laboratory services for the production of pharmaceuticals in the nature of research and development of new pharmaceutical products and testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; Consulting services in the field of pharmaceutical research and development.

Statistical data processing services, namely the compilation of statistics; data collection services, in particular statistics for the medical and biomedical fields; statistical recording and processing services, in particular in the medical, biomedical, and cosmetic fields; statistical collection and processing services for clinical trials for the cosmetics, pharmaceutical, and food industries; business consultancy in health care.

Medical services; pharmaceutical advice; consultancy in the field of human hygiene and beauty care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; consultancy in connection with the aforesaid services.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 8, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 8, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 19, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 4, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 30, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 12, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 7, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 7, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 7, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 7, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2025 TROA
REFUSAL PROCESSED BY IB
Dec 29, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 10, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 10, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 26, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 25, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 5, 2024 REPR